Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
News » New results on Bextra implicates whole cox-2 inhibitor class of drugs
 

New results on Bextra implicates whole cox-2 inhibitor class of drugs

The fear that all drugs of the cox-2 inhibitor class pose cardiovascular risks is becoming more real now that a new study has revealed that a third cox-2 inhibitor painkiller, Bextra, has been linked to an increased risk of heart attack or stroke. In the study Bextra use showed a tripled risk of heart attack and stroke compared to placebo. However, the subjects were all bypass patients and thus probably more at risk than the normal population. The cox-2 class is generally aimed at treating chronic pain of arthritis and other conditions. Vioxx has recently been banned from the market and Celebrex is still in use despite reports of increased cardiovascular risk associated with it. Researchers want all cox-2 inhibitors labeled with a black box warning highlighting the risks. The FDA is planning to hold a public forum on the viability of the whole cox-2 inhibitor class of drugs. The method of action of this class of drugs is blamed for the increased risk. Apparently, cox-2 inhibitor inhibit the activity of cox-2 causing prostacyclin levels to decrease which makes arteries more prone to clotting, high blood pressure, heart attack and stroke. Researchers point out that up to half of arthritis patients (who are most likely to use this class of drugs) also have underlying heart disease. An even greater risk was noted in a study on mice where aspirin was used in conjunction with cox-2 inhibitors. Researchers warn that doctors and consumers need to carefully weigh up the risks and benefits of using this class of drugs. Patients at high risk of cardiovascular disease should totally avoid this class of drugs.

Source: summary of medical news story as reported by ajc - HealthDay News

Related Disease Topics:

Article Source Details

About: New results on Bextra implicates whole cox-2 inhibitor class of drugs

Date: 18 January 2005

Source: ajc - HealthDay News

URL: http://www.ajc.com/health/content/shared-auto/healthnews/cora/523490.html

Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Trichotillomania is a rare compulsive hair pulling disorder
  • Triple test proposed for prostate cancer screening
  • Tuberculosis in children may be diagnosed using simpler test
  • Tumor recurrence in mesothelioma patients may be prevented by chemo prior to surgery
  • Turkish deaths from bird flu not pandemic
  • Two cancer patients suspected of spreading TB to 19 other people
  • Two hospitals agree to a 31 million and 395 million settlement
  • Two hospitals faced lawsuits over undiagnosed cancer leading to death
  • Two medical mistakes performed in same hospital
  • Two new drugs approved by FDA
  • Two people sue over wrongful sex-change
  • Two rare but painful conditions often misdiagnosed
  • Two sisters face different prognosis due to late diagnosis
  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise